However, we observed an elevated (without being significant) neurotoxicity index in ALS patients and in bulbar forms, as well as a general trend of KP intermediates and QUIN /KYNA ratio being higher in patients who developed severe forms. The gene discussed is NPPA; the disease is amyotrophic lateral sclerosis.